Details for 2018729051

Up to date per 03.04.2026

Actions

Title / Product Name

SUBSTITUIERTE INDOLIN DERIVATE ALS HEMMER DER VIRUSREPLIKATION DES DENGUE-VIRUS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018729051

EP Publication Number

3630724

E-Number

1386913

Language

PCT Number

EP18063029

Publication Date

08.04.2020 A

28.04.2021 B1

Registration Date

28.04.2021

AT Publication Date

15.05.2021

Application Date

18.05.2018

Registration Number

Priorities

22.05.2017

17172247

IPC

C07D 209/30 20060101AFI20181130BHEP

Maximum Duration of Protection

18.05.2038

Owner

Janssen Pharmaceuticals, Inc.1125 Trenton-Harbourton Road Titusville, NJ 08560US

Katholieke Universiteit LeuvenWaaistraat 6, Bus 5105 3000 LeuvenBE

Representative

No representatives present

Inventor

BONFANTI, Jean-Françoisc/o Janssen-Cilag 1 rue Camille Desmoulins TSA 91003 92787 Issy-les-Moulineaux Cedex 9FR

KESTELEYN, Bart, Rudolf, Romaniec/o Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE

BARDIOT, Dorothée, Alice, Marie-Evec/o Cistim Leuven vzw Gaston Geenslaan 2 3001 Leuven (Heverlee)BE

MARCHAND, Arnaud, Didier, Mc/o Cistim Leuven vzw Gaston Geenslaan 2 3001 Leuven (Heverlee)BE

COESEMANS, Erwinc/o Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE

DE BOECK, Benoît, Christian, Albert, Ghislainc/o Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE

RABOISSON, Pierre, Jean-Marie, Bernardc/o Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE